Thesis Abstract

Abstract
Cancer is a complex and heterogeneous group of diseases characterized by uncontrolled cell growth and proliferation. Understanding the molecular mechanisms underlying cancer development and progression is crucial for the development of targeted therapies and improved patient outcomes. MicroRNAs (miRNAs) have emerged as key regulators of gene expression and have been implicated in various aspects of cancer biology. This thesis aims to explore the role of miRNAs in cancer development and progression, focusing on their potential as diagnostic and prognostic biomarkers, as well as therapeutic targets. Chapter One provides an introduction to the topic, discussing the background of the study, problem statement, objectives, limitations, scope, significance, structure of the thesis, and definition of key terms. Chapter Two presents a comprehensive literature review covering ten key aspects related to miRNAs in cancer, including their biogenesis, functions, dysregulation in cancer, and potential clinical applications. Chapter Three outlines the research methodology, including study design, sample collection, miRNA profiling techniques, bioinformatics analysis, and statistical methods. Chapter Four presents a detailed discussion of the findings, highlighting the differential expression of miRNAs in various cancer types, their impact on cancer cell behavior, and their potential as therapeutic targets. The chapter also explores the interplay between miRNAs and other molecular pathways involved in cancer progression, such as cell proliferation, apoptosis, and metastasis. Additionally, the chapter discusses the challenges and future directions in miRNA research, including the development of novel therapeutic strategies and personalized medicine approaches. Chapter Five concludes the thesis by summarizing the key findings, discussing their implications for cancer research and clinical practice, and suggesting areas for future research. Overall, this thesis provides valuable insights into the role of miRNAs in cancer development and progression, highlighting their potential as biomarkers and therapeutic targets for improved cancer management and patient outcomes.

Thesis Overview